TRUCOM OPHTHALMIC SOLUTION is a combination of Brimonidine and Timolol which belongs to the group of medicines called an Alpha-adrenergic receptor agonist and Beta-adrenergic receptor inhibitors respectively. TRUCOM OPHTHALMIC SOLUTION is used to reduce the elevated intraocular pressure (pressure inside the eye) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately managed intraocular pressure.
Glaucoma is a disease which damages the optic nerve (nerve in the back of eye) because of excessive pressure inside the eye and may gradually lead to blindness. Ocular hypertension is a condition when pressure inside the eye rises higher than normal. Such conditions are characterized by halos, pain and blurred vision.
TRUCOM OPHTHALMIC SOLUTION is not recommended for use in patients with reactive airway disease such as bronchial asthma, severe chronic obstructive bronchitis and other severe chronic obstructive pulmonary disease (group of lung diseases causing difficulty in breathing).
It is also not recommended for use in patients having heart diseases such as sinus bradycardia (a type of slow heartbeat), 2nd or 3rd degree heart block, heart failure or cardiogenic shock. TRUCOM OPHTHALMIC SOLUTION should be used with caution in patients with liver and kidney problems.
TRUCOM OPHTHALMIC SOLUTION should be used in pregnant women only if clearly advised by the doctor and it is not recommended for use in breastfeeding women and children or adolescents (aged below 17 years).
The common side effects associated with the use of are TRUCOM OPHTHALMIC SOLUTION are eye redness, eye burning, stinging or pain in eyes, small breaks on the eye surface, inflammation in the eyelids and itching in eyes. Consult your doctor if any of the side effects worsen.
No content available
